Precision oncology small-molecule developer.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Series A Flindr Therapeutics, a Dutch precision-oncology biotech, raised a EUR20M Series A led by V-Bio Ventures. | $21.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.